Advertisement
Advertisement

ORMP

ORMP logo

Oramed Pharmaceuticals Inc.

4.52
USD
Sponsored
+0.22
+5.14%
Jun 25, 09:58 UTC -4
Open

Oramed Pharmaceuticals Inc. Profile

About

Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.

Info & Links

CEO

Nadav Kidron

Headquarters

1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK, NY 10036, UNITED STATES

Industry

Medical Products

Sector

Medical

Website

www.oramed.com

Auditor

Kesselman & Kesselman

Share holders

40

Employees

13

Oramed Pharmaceuticals Inc. Statistics

Valuation Measures

Market Capitalization2

185.03M

Enterprise Value

171.82M

Enterprise Value/EBITDA(ttm)

-12.16

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.70

Price to Cash(ytd)

38.80

Profitability

Gross Margin(ttm)

0.16%

Operating Margin(ttm)

--

Profit Margin(ttm)

-95.53%

Return on Equity(ttm)

-6.83%

Return on Invested Capital(ttm)

32.10%

Return on Assets(ttm)

-6.25%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-14.13M

Net Income Available to Common(ttm)

109.19M

Diluted EPS(ttm)

1.49

Share Statistics

Beta (5Y Monthly)

1.26

52-Week Change

108.34%

S&P 500 52-Week Change

20.96%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

40.93M

Dividend Yield

7.10%

Float4

33.25M

% Held by Insiders

17.80%

% Held by Institutions

12.73%

Balance Sheet

Total Cash(mrq)

65.84M

Total Cash Per Share(mrq)

1.61

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.98%

Quick Ratio(mrq)

6.98%

Book Value Per Share(mrq)

5.09

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.22

Free Cash Flow(ytd)

-9.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement